Clinical Trial Update: Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for UCMYM802 Injection in mesothelin-positive advanced malignant solid tumors, listing several cancer indications with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Duct Cancer
• Breast Cancer
• Colorectal Cancer
• Malignant Mesothelioma
• Ovarian Cancer
• Pancreatic Cancer
• Rectal Cancer

Drugs mentioned

• UCMYM802

Snippet

Sponsor: UTC Therapeutics Inc. | Conditions: Malignant Mesothelioma, Colorectal Cancer | Phase 1 | Status: UNKNOWN